Download PDF
Synlett 2010(7): 1059-1062  
DOI: 10.1055/s-0029-1219557
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

First Total Syntheses of (+)-Garvensintriol and (+)-5-epi-Garvensintriol

Debendra K. Mohapatra*, B. Prem Kumar, K. Bhaskar, Jhillu S. Yadav*
Organic Chemistry Division I, Indian Institute of Chemical Technology (CSIR), Uppal Road, Hyderabad 500007, India
Fax: +91(40)27160512; e-Mail: mohapatra@iict.res.in;
Further Information

Publication History

Received 24 December 2009
Publication Date:
26 February 2010 (online)

    Permissions and Reprints All articles of this category

Abstract

A concise and efficient carbohydrate-based approach for the total syntheses of (+)-garvensintriol and (+)-5-epi-garvensintriol is described in nine and six steps with 20% and 37% overall yield, respectively, starting from a known intermediate. A sequence of Grignard-assisted lactol opening with terminal alkyne, stereoselective keto reduction and oxidative lactonization are the key reactions.

Keywords

garvensintriol - goniotriol - cytotoxic - oxidative lactonization - Grignard-assisted lactol opening

    References and Notes

  • 1a Hoffmann HMR. Rabe J. Angew. Chem. Int. Ed.  1985,  24:  94 
    Google Scholar
  • 1b Negishi E. Kotora M. Tetrahedron Lett.  1997,  53:  6707 
    Google Scholar
  • 1c Collins I. J. Chem. Soc., Perkin Trans. 1  1999,  1377 
    Google Scholar
  • 1d Carter NB. Nadany AE. Sweeney JB. J. Chem. Soc., Perkin Trans. 1  2002,  2324 
    Google Scholar
  • 2a Davis-Coleman MT. Rivett DEA. Prog. Chem. Org. Nat. Prod.  1989,  55:  1 
    Google Scholar
  • 2b Dickinson JM. Nat. Prod. Rep.  1993,  10:  71 
    Google Scholar
  • 2c Collett LA. Davies-Coleman MT. Rivette DEA. Prog. Chem. Org. Nat. Prod.  1998,  75:  181 
    Google Scholar
  • 3a Chrusciel RA. Strohbach JW. Curr. Top. Med. Chem.  2004,  4:  1097 ; and references therein
    Google Scholar
  • 3b Chan KM. Rajab NF. Ishak NHA. Ali AM. Yusoff K. Din LB. Inayat-Hussain SH. Chem.-Biol. Interact.  2006,  159:  129 ; and references therein
    Google Scholar
  • 3c Newmeyer DD. Ferguson-Miller S. Cell  2003,  112:  481 ; and references therein
    Google Scholar
  • 3d Kikuchi H. Sasaki K. Sekiya J. Maeda Y. Amagai A. Kubohara Y. Ohsima Y. Bioorg. Med. Chem.  2004,  12:  3203 
    Google Scholar
  • 3e Richetti A. Fimiani V. Immunopharmacol. Immunotoxicol.  2003,  25:  441 
    Google Scholar
  • 4a Fang XP. Anderson JE. Qui XX. Kozlowski JF. Chang CJ. McLaughlin JL. Tetrahedron  1993,  49:  1563 
    Google Scholar
  • 4b Goh SH. Ee GCL. Chuah CH. Nat. Prod. Lett.  1995,  5:  255 
    Google Scholar
  • 4c McLaughlin JL. Chang CJ. Smith DL. In Human Medicinal Agents from Plants   Kinghorn AD. Baladrin A. American Chemical Society; Washington: 1993.  Vol. 534. p.112 
    Google Scholar
  • 5 Bermejo A. Blázquez MA. Rao KS. Cortes D. Phytochemistry  1998,  47:  135 
    CrossrefGoogle Scholar
  • 6 Alkofahi A. Ma WW. McKenzie AT. Byrn SR. McLaughlin JL. J. Nat. Prod.  1989,  52:  1371 
    CrossrefGoogle Scholar
  • 7 Koeski K. Ebata T. Matsushita H. Biosci. Biotech. Biochem.  1996,  60:  534 
    CrossrefGoogle Scholar
  • 8 Rycroft AD. Singh G. Wightman RH. J. Chem. Soc., Perkin Trans. 1  1995,  1667 
    CrossrefGoogle Scholar
  • 9 Mitsunobu O. Synthesis  1981,  1 
    Article in Thieme ConnectGoogle Scholar
  • 10 Corey EJ. Schmidt G. Tetrahedron Lett.  1979,  399 
    CrossrefGoogle Scholar
  • 11a Corey EJ. Bakshi RK. Shibata S. J. Am. Chem. Soc.  1987,  109:  5551 
    Google Scholar
  • 11b Corey EJ. Bakshi RK. Shibata S. Chen CP. Singh VK. J. Am. Chem. Soc.  1987,  109:  7925 
    Google Scholar
  • 11c Deloux L. Srebnik M. Chem. Rev.  1993,  93:  763 
    Google Scholar
  • 11d Corey EJ. Helal CJ. Angew. Chem. Int. Ed.  1998,  37:  1986 
    Google Scholar
  • 14 Hansen TM. Florence GJ. Lugo-Mas P. Chen J. Abrams JN. Forsyth CJ. Tetrahedron Lett.  2003,  44:  57 
    CrossrefGoogle Scholar
  • 16a Corey EJ. Gras JL. Ulrisch P. Tetrahedron Lett.  1976,  809 
    Google Scholar
  • 16b Bhatt MV. Kulkarni SV. Synthesis  1983,  249 
    Google Scholar
12

Analytical and Spectral Data of 8: white solid; mp 67 ˚C; [α]D ²5 +48.0 (c = 1.0, CHCl3). ¹H NMR (300 MHz, CDCl3): δ = 7.15-7.62 (m, 15 H), 4.60 (d, J = 6.0 Hz, 1 H), 4.46 (d, J = 13.6 Hz, 3 H), 4.29 (d, J = 11.3 Hz, 1 H), 3.96 (dd, J = 7.6, 2.7 Hz, 1 H), 3.48-3.72 (m, 4 H), 3.23 (br s, 1 H), 2.96 (br s, 1 H), 1.89 (br s, 1 H), 1.50-1.81 (m, 4 H). ¹³C NMR (75 MHz, CDCl3): δ = 137.9, 137.5, 137.5, 128.4, 128.3, 128.2, 128.0, 127.9, 127.7, 83.2, 80.3, 74.3, 71.7, 71.5, 70.7, 62.6, 28.2, 24.9. MS (ESI): m/z = 437 [M + H]+.

13

Analytical and Spectral Data of 17: white solid; mp 139 ˚C; [α]D ²5 = -22.2 (c = 1.5, CHCl3). IR (neat): 3395, 3029, 2960, 2911, 2859, 1746, 1453, 1396, 1259, 1086, 1028, 761, 705 cm-¹. ¹H NMR (300 MHz, CDCl3): δ = 7.17-7.51 (m, 15 H), 4.31-4.59 (m, 5 H), 4.19 (d, J = 11.3 Hz, 1 H), 3.99-4.12 (m, 2 H), 2.56-2.79 (m, 1 H), 2.19-2.55 (m, 2 H), 1.93-2.16 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 171.2, 137.7, 137.2, 128.6, 128.5, 128.4, 128.3, 128.2, 127.8, 127.7, 127.7, 81.8, 81.0, 74.4, 70.7, 70.5, 69.7, 26.0, 22.7. MS (ESI): m/z = 455 [M + Na]+.

15

Analytical and Spectral Data of 2: white solid; mp 163 ˚C; [α]D ²5 -10.1 (c = 0.5, EtOH). IR (neat): 3533, 3346, 2923, 1773, 1200, 1083, 1026, 897, 850, 705, 673 cm-¹. ¹H NMR (300 MHz, CD3OD): δ = 7.07-7.51 (m, 5 H), 4.77 (m, 2 H), 4.60 (br s, 3 H), 3.65-3.78 (m, 2 H), 2.09-2.62 (m, 4 H). ¹H NMR (300 MHz, DMSO-d 6): δ = 7.12-7.53 (m, 5 H), 5.35 (dd, J = 13.8, 3.8 Hz, 2 H), 4.84 (d, J = 4.9 Hz, 1 H), 4.71 (s, 2 H), 3.44-3.66 (m, 2 H), 1.95-2.48 (m, 4 H). ¹³C NMR (75 MHz, CD3OD): δ = 180.8, 142.2, 129.9, 128.9, 128.6, 83.1, 76.4, 75.3, 73.4, 29.8, 21.8. MS (ESI): m/z = 275 [M + Na]+.

17

Crystallographic data for the structure in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 755246 for 17. Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK [fax: +44 (1223)336033 or e-mail: deposit@ccdc.cam.ac.uk].

18

Analytical and Spectral Data of 7: white solid; mp 93 ˚C; [α]D ²5 +26.4 (c = 1.5, CHCl3). ¹H NMR (300 MHz, CDCl3): δ = 7.17-7.50 (m, 15 H), 4.40-4.64 (m, 4 H), 4.24 (d, J = 11.5 Hz, 1 H), 3.99 (t, J = 5.7 Hz, 1 H), 3.75 (t, J = 5.5 Hz, 1 H), 3.48 (t, J = 6.0 Hz, 2 H), 3.38 (d, J = 7.6 Hz, 1 H), 2.90 (br s, 3 H), 1.61-1.74 (m, 2 H), 1.38-1.52 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 137.9, 137.6, 137.5, 128.4, 128.3, 128.2, 128.0, 127.8, 82.6, 78.3, 74.3, 72.3, 72.0, 70.6, 62.5, 28.5, 26.5. MS (ESI): m/z = 437 [M + H]+.

19

Analytical and Spectral Data of 19: white solid; mp 127 ˚C; [α]D ²5 = +3.2 (c = 0.5, CHCl3). IR (neat): 3464, 3030, 2923, 1736, 1494, 1452, 1354, 1239, 1201, 1090, 1055, 741, 700, 579 cm-¹. ¹H NMR (300 MHz, CDCl3): δ = 7.20-7.54 (m, 15 H), 4.75 (d, J = 3.6 Hz, 1 H), 4.60 (d, J = 11.7 Hz, 1 H), 4.41-4.55 (m, 3 H), 4.31 (d, J = 11.3 Hz, 1 H), 3.95 (br s, 1 H), 3.74 (dd, J = 8.7, 1.5 Hz, 1 H), 2.58-2.76 (m, 1 H), 2.88 (br s, 1 H), 2.35-2.56 (m, 1 H), 2.78-2.15 (m, 1 H), 1.57-1.78 (m, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 169.9, 137.7, 137.5, 136.3, 128.4, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 80.7, 80.5, 71.3, 71.1, 71.0, 68.2, 25.4, 23.0. MS (ESI): m/z = 455 [M + Na]+.

20

Analytical and Spectral Data of 1: [α]D ²5 +70.3 (c = 1.5, MeOH). IR (neat): 3396, 2921, 1756, 1453, 1371, 1270, 1195, 1079, 1043, 917, 815, 705, 578 cm-¹. ¹H NMR (300 MHz, CDCl3): δ = 7.28-7.51 (m, 5 H), 4.95 (t, J = 6.2 Hz, 1 H), 4.85 (d, J = 6.6 Hz, 1 H), 3.93 (t, J = 7.6 Hz, 1 H), 3.59 (dd, J = 7.9, 1.3 Hz, 1 H), 2.58-2.75 (m, 1 H), 2.39-2.56 (m, 1 H), 2.14-2.38 (m, 2 H), 1.71 (br s, 2 H). ¹³C NMR (75 MHz, CD3OD): δ = 180.9, 142.2, 128.6, 128.9, 129.1, 81.3, 76.6, 75.6, 74.4, 29.5, 24.4. MS (ESI): m/z = 253 [M + H]+.